HK-based buyout firm Baring to invest $100m in Chinese drug maker Hutchmed

HK-based buyout firm Baring to invest $100m in Chinese drug maker Hutchmed

Source: Michael Longmire/Unsplash

Eudora Wang

09 April, 2021

Asia-PacificBaring Private Equity AsiaHutchison China MediTechHutchmed

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.